Reliv Acquires Exclusive Rights to 'Superfood' Lunasin

Reliv Acquires Exclusive Rights to 'Superfood' Lunasin

Deal Positions Reliv as Industry Leader in Emerging Field of Nutritional
Epigenetics

CHESTERFIELD, Mo., July 24, 2013 (GLOBE NEWSWIRE) -- Reliv International, Inc.
(Nasdaq:RELV), a maker of nutritional supplements that promote optimal health,
today announced that it has entered into an exclusive license for the
intellectual property of Soy Labs LLC related to the nutritional ingredient
lunasin. Lunasin is a naturally occurring peptide research has identified as
the key to many of soy's documented health benefits, from cholesterol
reduction to general cellular health.

The license covers an issued patent and several patent applications related to
lunasin and soy-related peptides, proprietary information and manufacturing
processes of Soy Labs. Further, the arrangement allows certain Soy Labs
employees to join the Reliv corporate staff.The License Agreement is for a
term covering the entire period of the basic patent and then provides for a
full assignment of all of the technology rights to Reliv. Reliv will make
minimum payments of $1,150,000 initially and additional minimum payments over
a five year period totaling $850,000. In addition, Reliv will pay a royalty at
varying rates over the term of the agreement.

"This is a major step for Reliv and elevates our company to a unique status in
the nutrition industry," said Ryan Montgomery, Reliv president. "For the first
time we own an ingredient in its entirety, from the extraction process to the
patented mechanisms of action within the body. And lunasin isn't just any
ingredient; it's the world's first epigenetic superfood."

How Lunasin Works

Lunasin is the first nutritional compound identified to affect gene expression
and promote optimal health at the epigenetic level. The epigenome, which
literally means "beyond the genome," is a higher level of complexity within
the cell. It acts like a dimmer for lights, controlling which genes are used,
when they are used and how much they are used.

Lunasin can attach itself to the epigenome. As a result, it can increase
expression of important genes needed for normal cell functioning and protect
the cells from environmental damage once it occurs. More than 50 published
papers from more than 25 research institutions demonstrate lunasin's multiple
health benefits. Learn more about lunasin and epigenetics.

"We've always endeavored to remain on the cutting edge of nutrition science in
formulating our products at Reliv. And with the acquisition of lunasin, we are
now leading the industry in the budding field of nutritional epigenetics,"
said Dr. Carl W. Hastings, vice chairman and chief scientific officer.

"New research shows that through nutrition people can influence which genes
are expressed," he added. "Reliv is committed to building on this emerging
science and developing nutritional solutions that help people take control of
their health."

'Tremendous Opportunity'

Reliv's license of the intellectual property behind Soy Labs lunasin
production and marketing stems from a joint research and development
partnership formed in August 2011 among Reliv, Soy Labs and the Missouri Plant
Science Center. That partnership resulted in the creation of LunaRich® soy
powder and LunaRich X™, Reliv-exclusive products made from non-GMO soybean
varieties with the highest concentration of bioactive lunasin and manufactured
through a proprietary mechanical process (vs. chemical) that maintains the
lunasin's bioactivity.

"Acquiring lunasin not only gives us direct control over the entire LunaRich X
production process and technologies, it also opens up opportunities for
further research and development with lunasin and other plant-based
ingredients," Hastings said. "We're beyond excited about what this will mean
for Reliv consumers around the globe."

"Epigenetics has hit the mainstream, and we believe nutritional epigenetics
will soon follow," Montgomery added. "Reliv is the only company talking about
it because, right now, we're the only company who can. We believe lunasin
positions our company and our distributors to take full advantage of a
tremendous growth opportunity."

About Reliv International, Inc.
Reliv International, based in Chesterfield, MO, produces nutritional
supplements that promote optimal nutrition along with premium skincare
products. Reliv supplements address essential nutrition, weight loss, athletic
performance, digestive health, women's health, anti-aging and healthy energy.
Reliv is the exclusive provider of LunaRich® products, which optimize levels
of lunasin, the peptide behind many of soy's health benefits. The company
sells its products through an international network marketing system of
independent distributors in 16 countries. Learn more about Reliv at
www.reliv.com, or on Facebook, Twitter or YouTube.

CONTACT: For more information, contact:
        
         Steve Albright
         Chief Financial Officer
         (636) 733-1305
        
         Fred Nielson
         Investor Relations
         (636) 733-1314